Skip to main content
SpringerLink
Log in

Gastric Toxicity: A Problem with Low-Dose Aspirin

  • Drug Reactions and Interactions
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Low-dose aspirin beneficial in myocardial infarction. Drug Ther Perspect 1997; 10 (4): 6–8

    Article  Google Scholar 

  2. Guslandi M. Gastric toxicity of antiplatelet therapy with low-dose aspirin. Drugs 1997 Jan; 53 (1): 1–5

    Article  PubMed  CAS  Google Scholar 

  3. Bochner F, Lloyd JV. Aspirin for myocardial infarction: clinical pharmacokinetic considerations. Clin Pharmacokinet 1995; 28 (6): 433–8

    Article  PubMed  CAS  Google Scholar 

  4. Konturek JW, Dembinski A, Stoll R, et al. Mucosal adaptation to aspirin-induced gastric damage in humans: studies on blood flow, gastric mucosal growth and neutrophil activation. Gut 1994; 35: 1197–204

    Article  PubMed  CAS  Google Scholar 

  5. Savon JJ, Allen ML, DiMarino AJ, et al. Gastrointestinal blood loss with low dose (325mg) plain and enteric-coated aspirin administration. Am J Gastroenterol 1995; 90: 581–5

    PubMed  CAS  Google Scholar 

  6. Slattery J, Warlow CP, Shorrock CJ, et al. Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin — analysis of gastrointestinal bleeding during the UK-TIA trial. Gut 1995; 37: 509–11

    Article  PubMed  CAS  Google Scholar 

  7. Weil J, Colin-Jones D, Langman MJS, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. Br Med J 1995; 310: 827–30

    Article  CAS  Google Scholar 

  8. Kaufman DW, Kelly JP, Sheehan JE, et al. Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther 1993; 53: 485–94

    Article  PubMed  CAS  Google Scholar 

  9. Lee M, Cruer B, Feldman M. Dose effects of aspirin and gastric prostaglandins and stomach mucosal injury. Ann Intern Med 1994; 120: 184–9

    PubMed  CAS  Google Scholar 

  10. Lanza F, Peace K, Gustitus L, et al. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration. Am J Gastroenterol 1988; 83: 143–6

    PubMed  CAS  Google Scholar 

  11. Goddard AF, Donnelly MT, Filipowicz B, et al. Low-dose misoprostol as prophylaxis against low-dose aspirin-induced gastroduodenal mucosal injury [abstract]. Gut 1996; 39 Suppl. 1: A33

    Google Scholar 

  12. British National Formulary No. 33. London: The Pharmaceutical Press, 1997 Mar: 39

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gastric Toxicity: A Problem with Low-Dose Aspirin. Drugs Ther. Perspect 10, 12–14 (1997). https://doi.org/10.2165/00042310-199710040-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199710040-00004

Keywords

Search

Navigation